AI assistant
Sending…
LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2011
Dec 27, 2011
32814_dirs_2011-12-27_c8b30afe-ee9e-4f57-8fe8-496f4916107e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEXICON PHARMACEUTICALS, INC./DE (LXRX)
CIK: 0001062822
Period of Report: 2011-12-22
Reporting Person: MAIN ALAN J (EVP, Pharmaceutical Research)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-12-22 | Common Stock | M | 19211 | $1.13 | Acquired | 64184 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-12-22 | Subscription Rights (Right to Buy) | $1.13 | M | 44973 | Disposed | 2011-12-22 | Common Stock (19211) | Direct |
Footnotes
F1: Each subscription right reflects a basic subscription privilege entitling the holder to purchase 0.427175 shares of common stock and an oversubscription privilege entitling the holder to purchase additional shares of common stock under certain circumstances.